Founder and Chairman, Sycamore Networks
Serial Entrepreneur and Investor
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
CEO and co-founder of BoostSuite
Modes of administration other than oral or intravenous injection are usually preferred when drug delivery is directed to a specific tissue, such as the skin or eye. Non-traditional routes to systemic delivery, such as pulmonary, transdermal, transmuscosal, also promise substantial benefits. But they entail special delivery challenges. Biocom has organized a panel of local experts to discuss how these challenges are being overcome. More information and online registration is here.